Predicate |
Object |
contentType |
Journal Article|Review |
endingPage |
72 |
issn |
1558-822X 1558-8211 |
issueIdentifier |
1 |
pageRange |
67-72 |
publicationName |
Current Hematologic Malignancy Reports |
startingPage |
67 |
bibliographicCitation |
Horwitz SM. The Emerging Role of Histone Deacetylase Inhibitors in Treating T-cell Lymphomas. Current Hematologic Malignancy Reports. 2010 Nov 16;6(1):67–72. doi: 10.1007/s11899-010-0067-5. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9a92f2b1c30c41c07adc30dab3b758d0 |
date |
2010-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
identifier |
https://pubmed.ncbi.nlm.nih.gov/21080243 https://doi.org/10.1007/s11899-010-0067-5 |
isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/33059 https://portal.issn.org/resource/ISSN/1558-822X https://portal.issn.org/resource/ISSN/1558-8211 |
language |
English |
source |
https://www.crossref.org/ https://scigraph.springernature.com/ https://pubmed.ncbi.nlm.nih.gov/ |
title |
The Emerging Role of Histone Deacetylase Inhibitors in Treating T-cell Lymphomas |
discusses |
http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0527853 |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9861 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.5.1.98 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9857 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8390 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8388 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5352062 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9860 |